Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with systemic lupus erythematosus (an autoimmune disease where the immune system attacks healthy tissue, sometimes called SLE or lupus)
- People who have been diagnosed with systemic lupus erythematosus alongside a lung condition called interstitial lung disease (where the lungs become scarred or inflamed over time)
Who may not be able to join:
- People who have lung or chest conditions other than interstitial lung disease
- People who are currently receiving biological blocking antibody treatments (a type of medication that targets specific parts of the immune system) (confirm with trial site)
- People who are currently being treated with immunosuppressive drugs (medications that reduce the activity of the immune system)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 01069152448
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
interleukin 23
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.